Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Maharashtra-healthcare"

2 News Found

Wockhardt hosts Mother’s Day walkathon to promote women’s health and wellness
Hospitals | May 12, 2026

Wockhardt hosts Mother’s Day walkathon to promote women’s health and wellness

Women’s wellness initiative promoted preventive healthcare, fitness, and self-care awareness across the Mira Bhayandar community

HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur
Hospitals | May 04, 2026

HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur

Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Moderna reshapes leadership and ops model as it pushes into oncology, rare disease

Siegfried opens major API manufacturing facility in Germany

Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Dr. Manjiri Bakre CEO and Founder, OncoStem Diagnostics
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
Akhil Ravi Chief Executive Officer, Aurigene Pharmaceutical Services Limited
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation

Packaging